| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 10724 | 2021 |
| Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients J Liu, S Li, J Liu, B Liang, X Wang, H Wang, W Li, Q Tong, J Yi, L Zhao, ... EBioMedicine 55, 2020 | 1859 | 2020 |
| Liver injury during highly pathogenic human coronavirus infections L Xu, J Liu, M Lu, D Yang, X Zheng Liver international 40 (5), 998-1004, 2020 | 1064 | 2020 |
| Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS‐CoV, MERS‐CoV, and 2019‐nCoV J Liu, X Zheng, Q Tong, W Li, B Wang, K Sutter, M Trilling, M Lu, U Dittmer, ... Journal of medical virology 92 (5), 491-494, 2020 | 795 | 2020 |
| Hepatitis B virus suppresses toll‐like receptor–mediated innate immune responses in murine parenchymal and nonparenchymal liver cells J Wu, Z Meng, M Jiang, R Pei, M Trippler, R Broering, A Bucchi, JP Sowa, ... Hepatology 49 (4), 1132-1140, 2009 | 395 | 2009 |
| Toll‐like receptor‐mediated control of HBV replication by nonparenchymal liver cells in mice J Wu, M Lu, Z Meng, M Trippler, R Broering, A Szczeponek, F Krux, ... Hepatology 46 (6), 1769-1778, 2007 | 335 | 2007 |
| SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19 J Wu, B Liang, C Chen, H Wang, Y Fang, S Shen, X Yang, B Wang, ... Nature communications 12 (1), 1813, 2021 | 279 | 2021 |
| Enhancing Virus-Specific Immunity In Vivo by Combining Therapeutic Vaccination and PD-L1 Blockade in Chronic Hepadnaviral Infection J Liu, E Zhang, Z Ma, W Wu, A Kosinska, X Zhang, I Möller, P Seiz, ... PLoS pathogens 10 (1), e1003856, 2014 | 278 | 2014 |
| Excessive neutrophils and neutrophil extracellular traps in COVID-19 J Wang, Q Li, Y Yin, Y Zhang, Y Cao, X Lin, L Huang, D Hoffmann, M Lu, ... Frontiers in immunology 11, 2063, 2020 | 267 | 2020 |
| Toll‐like receptor‐induced innate immune responses in non‐parenchymal liver cells are cell type‐specific J Wu, Z Meng, M Jiang, E Zhang, M Trippler, R Broering, A Bucchi, F Krux, ... Immunology 129 (3), 363-374, 2010 | 267 | 2010 |
| Modulation of hepatitis B virus replication and hepatocyte differentiation by MicroRNA‐1 X Zhang, E Zhang, Z Ma, R Pei, M Jiang, JF Schlaak, M Roggendorf, M Lu Hepatology 53 (5), 1476-1485, 2011 | 228 | 2011 |
| Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion Q Shen, VR Cicinnati, X Zhang, S Iacob, F Weber, GC Sotiropoulos, ... Molecular cancer 9, 1-12, 2010 | 225 | 2010 |
| Transmission of hepatitis C virus to children and husbands by women infected with contaminated anti-D immunoglobulin H Meisel, A Reip, B Faltus, DH Krüger, H Porst, M Wiese, M Lu, ... The Lancet 345 (8959), 1209-1211, 1995 | 198 | 1995 |
| RNA interference-induced innate immunity, off-target effect, or immune adjuvant? Z Meng, M Lu Frontiers in immunology 8, 251984, 2017 | 190 | 2017 |
| MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity L Xu, S Beckebaum, S Iacob, G Wu, GM Kaiser, A Radtke, C Liu, I Kabar, ... Journal of hepatology 60 (3), 590-598, 2014 | 177 | 2014 |
| Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection JM Zhang, Y Xu, XY Wang, YK Yin, XH Wu, XH Weng, M Lu Clinical infectious diseases 44 (9), 1161-1169, 2007 | 172 | 2007 |
| Immunostaining of PD-1/PD-Ls in liver tissues of patients with hepatitis and hepatocellular carcinoma BJ Wang, JJ Bao, JZ Wang, Y Wang, M Jiang, MY Xing, WG Zhang, JY Qi, ... World journal of gastroenterology: WJG 17 (28), 3322, 2011 | 163 | 2011 |
| Superinfection exclusion by T-even-type coliphages MJ Lu, U Henning Trends in microbiology 2 (4), 137-139, 1994 | 151 | 1994 |
| Toll-like receptor (TLR)-mediated innate immune responses in the control of hepatitis B virus (HBV) infection E Zhang, M Lu Medical Microbiology and Immunology 204, 11-20, 2015 | 130 | 2015 |
| O-GlcNAc transferase promotes influenza A virus–induced cytokine storm by targeting interferon regulatory factor–5 Q Wang, P Fang, R He, M Li, H Yu, L Zhou, Y Yi, F Wang, Y Rong, ... Science Advances 6 (16), eaaz7086, 2020 | 129 | 2020 |
Joerg SchlaakProfessor, Kliniken Essen Mitte, EssenVerified email at kem-med.com
